Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

The drug’s developer, Cereno Scientific, believes its oral therapy could have a major impact on the pulmonary arterial ...

New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring.

One example is a disease called phenylketonuria (PKU). It is caused by a change in the PAH gene. The PAH gene contains the information required to make the enzyme which breaks down phenylalanine ...

The PKU-associated enzyme deficiency was determined biochemically in the 1950s—long before the PAH-encoding gene was mapped to human chromosome 12 and cloned in 1983. Specifically, Dr. Willard ...